TOKYO -- Major Japanese pharmaceutical companies are reducing their business in Russia, joining their global peers in pulling back as the nation's invasion of Ukraine makes it tougher to operate there.
Daiichi Sankyo has halted sales of some of its drugs to local distributors in Russia, while Eiken Chemical has tentatively stopped supplying reagents used in blood tests for cancer.
